{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T09:53:28Z","timestamp":1792058008751,"version":"4.4.0"},"reference-count":86,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Otolaryngologic Clinics of North America"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.otc.2010.10.003","type":"journal-article","created":{"date-parts":[[2010,11,20]],"date-time":"2010-11-20T09:24:13Z","timestamp":1290245053000},"page":"57-78","source":"Crossref","is-referenced-by-count":41,"title":["Oral Infections and Antibiotic Therapy"],"prefix":"10.1016","volume":"44","author":[{"given":"Marilyn E.","family":"Levi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent D.","family":"Eusterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.otc.2010.10.003_bib1","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/000348940611500207","article-title":"Redefining parapharyngeal space infections","volume":"115","author":"Sichel","year":"2006","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.otc.2010.10.003_bib2","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1034\/j.1600-0757.2002.280109.x","article-title":"Microbiology and treatment of dental abscesses and periodontal endodontic lesions","volume":"28","author":"Dahlen","year":"2002","journal-title":"Periodontol 2000"},{"key":"10.1016\/j.otc.2010.10.003_bib3","doi-asserted-by":"crossref","first-page":"14547","DOI":"10.1073\/pnas.96.25.14547","article-title":"Current concepts in periodontal pathogenesis. Dent bacterial diversity within the human subgingival crevice","volume":"96","author":"Preshaw","year":"1999","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.otc.2010.10.003_bib4","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1128\/AEM.69.3.1687-1694.2003","article-title":"Prevalence of bacteria of division TM7 in human subgingival plaque and their association with disease","volume":"69","author":"Brinig","year":"2003","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.otc.2010.10.003_bib5","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1093\/clinids\/6.Supplement_1.S62","article-title":"Anaerobes as normal oral flora","volume":"6","author":"Sutter","year":"1984","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.otc.2010.10.003_bib6","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1126\/science.1177486","article-title":"Bacterial community variation in human body habitats over space and time","volume":"326","author":"Costello","year":"2009","journal-title":"Science"},{"issue":"Suppl 1","key":"10.1016\/j.otc.2010.10.003_bib7","first-page":"517","article-title":"Recent taxonomic changes and terminology update of clinically significant anaerobic gram-negative bacteria (excluding spirochetes)","volume":"35","author":"Jousimies-Somer","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.otc.2010.10.003_bib8","series-title":"Principles and practice of infectious diseases","first-page":"855","article-title":"Infections of the oral cavity, neck and head","author":"Chow","year":"2010"},{"key":"10.1016\/j.otc.2010.10.003_bib9","series-title":"Infections of the head and neck","first-page":"148","article-title":"Odontogenic infections","author":"Chow","year":"1987"},{"key":"10.1016\/j.otc.2010.10.003_bib10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0140-6736(07)60031-2","article-title":"Dental caries","volume":"369","author":"Selwitz","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.otc.2010.10.003_bib11","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1600-051X.1998.tb02454.x","article-title":"Subgingival microbiota in healthy, well-maintained elder and periodontitis subjects","volume":"25","author":"Haffajee","year":"1998","journal-title":"J\u00a0Clin Periodontol"},{"issue":"Suppl 2","key":"10.1016\/j.otc.2010.10.003_bib12","doi-asserted-by":"crossref","first-page":"S194","DOI":"10.1086\/516205","article-title":"Role of Porphyromonas gingivalis, Prevotella intermedia, and Prevotella nigrescens in extraoral and some odontogenic infections","volume":"25","author":"Matto","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.otc.2010.10.003_bib13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.17796\/jcpd.28.1.uwjxq61753506255","article-title":"Microbiology and management of endodontic infections in children","volume":"28","author":"Brook","year":"2003","journal-title":"J\u00a0Clin Pediatr Dent"},{"key":"10.1016\/j.otc.2010.10.003_bib14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11908-005-0019-8","article-title":"An approach to oral infections and their management","volume":"7","author":"Hull","year":"2005","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.otc.2010.10.003_bib15","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.idc.2007.03.003","article-title":"Mucositis in the cancer patient and immunosuppressed host","volume":"21","author":"Epstein","year":"2007","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.otc.2010.10.003_bib16","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/0966-842X(94)90614-9","article-title":"Molecular structure of penicillin-binding proteins and beta-lactamases","volume":"2","author":"Ghuysen","year":"1994","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.otc.2010.10.003_bib17","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.cell.2007.06.049","article-title":"A\u00a0common mechanism of cellular death induced by bactericidal antibiotics","volume":"130","author":"Kohanski","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.otc.2010.10.003_bib18","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S0025-7125(16)32582-2","article-title":"The isoxazolyl penicillins: oxacillin, cloxacillin, and dicloxacillin","volume":"54","author":"Marcy","year":"1970","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.otc.2010.10.003_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.35.1.1","article-title":"Antimicrobial resistance among enterococci","volume":"35","author":"Herman","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.otc.2010.10.003_bib20","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0002-9343(93)90063-U","article-title":"Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis and epidemiology with implications for prevention and management","volume":"94","author":"Mulligan","year":"1993","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.otc.2010.10.003_bib21","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/infdis\/135.6.999","article-title":"Comparisons of concentrations of amoxicillin in serum and middle ear fluid of children with chronic otitis media","volume":"155","author":"Klimek","year":"1977","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.otc.2010.10.003_bib22","doi-asserted-by":"crossref","unstructured":"Murphy TF. Haemophilus species (including H. influenzae and chancroid). In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases. 7th edition. Philadelphia (PA): Churchill, Livingstone Elsevier; 2010. p. 2911\u20139.","DOI":"10.1016\/B978-0-443-06839-3.00225-3"},{"issue":"1","key":"10.1016\/j.otc.2010.10.003_bib23","first-page":"341","article-title":"Proceedings: platelet dysfunction induced by parenteral administration of carbenicillin and ticarcillin","volume":"34","author":"Johnson","year":"1975","journal-title":"Thromb Diath Haemorrh"},{"key":"10.1016\/j.otc.2010.10.003_bib24","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1542\/peds.2004-1276","article-title":"A\u00a0review of evidence supporting the American Academy of Pediatrics recommendation for prescribing cephalosporin antibiotics for penicillin-allergic patients","volume":"115","author":"Pichichero","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.otc.2010.10.003_bib25","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1001\/archsurg.1992.01420010097015","article-title":"Guidelines for clinical care: anti-infective agents for intra-abdominal infections","volume":"127","author":"Bohnen","year":"1992","journal-title":"Arch Surg"},{"key":"10.1016\/j.otc.2010.10.003_bib26","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1086\/516532","article-title":"A\u00a0global gene pool for high-level cephalosporin resistance in commensal Streptococcus species and Streptococcus pneumoniae","volume":"176","author":"Reichmann","year":"1997","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.otc.2010.10.003_bib27","doi-asserted-by":"crossref","unstructured":"Andes DR, Craig WA. Cephalosporins. In: Mandell GL, Douglas RG, Bennett JE, editors. Principles and practice of infectious diseases. 7th edition. Philadelphia (PA): Churchill, Livingstone Elsevier; 2010. p. 323\u201339.","DOI":"10.1016\/B978-0-443-06839-3.00022-9"},{"key":"10.1016\/j.otc.2010.10.003_bib28","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1056\/NEJM199001183220301","article-title":"A\u00a0comparison of ceftriaxone and cefuroxime for the treatment of bacterial meningitis in children","volume":"322","author":"Schaad","year":"1990","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.otc.2010.10.003_bib29","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1093\/clinids\/24.Supplement_1.S85","article-title":"Antibiotic resistance in Streptococcus pneumoniae","volume":"24","author":"Tomasz","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.otc.2010.10.003_bib30","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1056\/NEJM199703063361007","article-title":"Treatment of bacterial meningitis","volume":"336","author":"Quagliarello","year":"1997","journal-title":"N\u00a0Engl J Med"},{"issue":"Suppl B","key":"10.1016\/j.otc.2010.10.003_bib31","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/jac\/32.suppl_B.187","article-title":"Cefepime versus cefotaxime in the treatment of lower respiratory tract infection","volume":"32","author":"Barckow","year":"1993","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.otc.2010.10.003_bib32","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1128\/AAC.42.4.729","article-title":"Cefepime versus ceftriaxone for empiric treatment of hospitalized patients with community-acquired pneumonia","volume":"42","author":"Zervos","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.otc.2010.10.003_bib33","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.diagmicrobio.2007.06.023","article-title":"Activity of ceftobiprole against community-associated methicillin-resistant Staphylococcus aureus isolates recently recovered from US military trainees","volume":"59","author":"Yun","year":"2007","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"5","key":"10.1016\/j.otc.2010.10.003_bib34","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1086\/526528","article-title":"Ceftobiprole: a new option for treatment of skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus","volume":"46","author":"Widmer","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.otc.2010.10.003_bib35","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1086\/526527","article-title":"A\u00a0randomized, double-blind trial comparing ceftobiprole medocaril with vancomycin plus ceftazidime plus ceftazidime for the treatment of patients with complicated skin and skin-structure infections","volume":"46","author":"Noel","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.otc.2010.10.003_bib36","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/clinids\/21.3.544","article-title":"Meropenem versus tobramycin plus clindamycin for treatment of intraabdominal infections: results of a prospective, randomized double-blind clinical trial","volume":"21","author":"Condon","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.otc.2010.10.003_bib37","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0002-9610(97)00137-2","article-title":"Meta-analysis of the clinical outcome of carbapenem monotherapy in the adjunctive treatment of intra-abdominal infections","volume":"174","author":"Chang","year":"1997","journal-title":"Am J Surg"},{"key":"10.1016\/j.otc.2010.10.003_bib39","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1473-3099(10)70143-2","article-title":"Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological and epidemiological study","volume":"10","author":"Kumarasamy","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.otc.2010.10.003_bib40","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s10096-008-0537-z","article-title":"Assessing antibiotic therapy for Acinetobacter baumannii infections in an academic medical center","volume":"27","author":"Dauner","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.otc.2010.10.003_bib41","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1086\/529198","article-title":"Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options","volume":"46","author":"Maragakis","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.otc.2010.10.003_bib42","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1128\/AAC.29.4.670","article-title":"Cerebrospinal fluid penetration of imipenem and cilastatin (primaxin) in children with central nervous system infections","volume":"29","author":"Jacobs","year":"1986","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.otc.2010.10.003_bib43","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1086\/590064","article-title":"Pharmacokinetic and pharmacodynamic properties of meropenem","volume":"47","author":"Nicolau","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.otc.2010.10.003_bib44","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/0002-9343(88)90071-X","article-title":"Factors predisposing to seizures in seriously ill patients receiving antibiotics: experience with imipenem\/cilastatin","volume":"84","author":"Calandra","year":"1988","journal-title":"Am J Med"},{"key":"10.1016\/j.otc.2010.10.003_bib45","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1086\/590065","article-title":"Update on the efficacy and tolerability of meropenem in the treatment of serious bacterial infections","volume":"47","author":"Mohr","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"14","key":"10.1016\/j.otc.2010.10.003_bib46","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.2165\/00003495-200868140-00007","article-title":"Doripenem: a review of its use in the treatment of bacterial infections","volume":"68","author":"Keam","year":"2008","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.otc.2010.10.003_bib47","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/CCM.0b013e3181691b99","article-title":"Efficacy and safety of intravenous infusion of doripenem versus imipenem in ventilator-associated pneumonia: a multicenter, randomized study","volume":"36","author":"Chastre","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1016\/j.otc.2010.10.003_bib48","doi-asserted-by":"crossref","first-page":"S594","DOI":"10.1093\/clinids\/7.Supplement_4.S594","article-title":"Aztreonam: antibacterial activity, beta-lactamase stability, and interpretive standards and quality control guidelines for disk-diffusion susceptibility tests","volume":"7","author":"Barry","year":"1985","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.otc.2010.10.003_bib49","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1128\/AAC.33.6.797","article-title":"Aminoglycoside induced hearing loss in humans","volume":"33","author":"Brummett","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.otc.2010.10.003_bib50","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1001\/archotol.124.10.1174","article-title":"What role do systemic corticosteroids, immunotherapy, and antifungal drugs play in the therapy of allergic fungal rhinosinusitis?","volume":"124","author":"Ferguson","year":"1998","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.otc.2010.10.003_bib51","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/infdis\/165.6.1026","article-title":"High frequency audiometric monitoring for early detection of aminoglycoside ototoxicity","volume":"165","author":"Fausti","year":"1992","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.otc.2010.10.003_bib52","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1128\/AAC.38.11.2517","article-title":"Proposed molecular and cellular mechanism of aminoglycoside ototoxicity","volume":"38","author":"Hutchin","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.otc.2010.10.003_bib53","first-page":"333","article-title":"Gentamicin binding to the isolated crista ampullaris of the guinea pig","volume":"37","author":"Amiko","year":"1982","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"10.1016\/j.otc.2010.10.003_bib54","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1001\/jama.279.7.541","article-title":"Gentamicin-induced bilateral vestibular hypofunction","volume":"279","author":"Minor","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.otc.2010.10.003_bib55","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/00000542-197806000-00008","article-title":"Antibiotic-induced paralysis of the mouse phrenic nerve-hemidiaphragm preparation, and reversibility by calcium and by neostigmine","volume":"48","author":"Singh","year":"1978","journal-title":"Anesthesiology"},{"key":"10.1016\/j.otc.2010.10.003_bib56","unstructured":"Fairbanks DNF. Pocket guide to antimicrobial therapy in otolaryngology-head and neck surgery. 13th edition. Alexandria (VA): American Academy of Otolaryngology-Head and Neck Surgery Foundation, Inc; 2007. p. 10\u201311."},{"key":"10.1016\/j.otc.2010.10.003_bib57","doi-asserted-by":"crossref","unstructured":"Sivapalasingam S, Steigbigel NH. Macrolides, clindamycin and ketolides. In: Mandell GL, Douglas RG, Bennett JE. Principles and practice of infectious diseases. 7th edition. Philadelphia (PA): Churchill, Livingstone Elsevier; 2010. p. 427\u201348.","DOI":"10.1016\/B978-0-443-06839-3.00030-8"},{"key":"10.1016\/j.otc.2010.10.003_bib58","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/106002809202600112","article-title":"The new macrolide antibiotics: azithromycin, clarithromycin, dirithromycin, roxithromycin","volume":"26","author":"Bahal","year":"1992","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.otc.2010.10.003_bib59","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1128\/AAC.45.1.67-72.2001","article-title":"Susceptibilities of Haemophilus influenzae and Moraxella catarrhalis to ABT-773 compared to their susceptibilities to 11 other agents","volume":"45","author":"Credito","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.otc.2010.10.003_bib60","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1128\/AAC.41.5.1037","article-title":"Antianaerobic activity of the ketolide RU 64004 compared to activities of four macrolides, five beta-lactams, clindamycin and metronidazole","volume":"41","author":"Ednie","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.otc.2010.10.003_bib61","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1128\/AAC.01435-06","article-title":"National survey on the susceptibility of the Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004","volume":"51","author":"Snydman","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.otc.2010.10.003_bib62","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1093\/clinids\/24.5.874","article-title":"Clindamycin resistance in the Bacteroides fragilis group: association with hospital acquired infections","volume":"24","author":"Dalmau","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.otc.2010.10.003_bib63","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/jac\/dkg120","article-title":"Faropenem, a new penem: antibacterial activity against selected anaerobic and fastidious periodontal isolates","volume":"51","author":"Milazzo","year":"2003","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.otc.2010.10.003_bib64","doi-asserted-by":"crossref","unstructured":"Salvatore M, Meyers BR. Metronidazole. In: Mandell GL, Douglas RG, Bennett JE. Principles and practice of infectious diseases. 7th edition. Philadelphia (PA): Churchill, Livingstone Elsevier; 2010. p. 419\u201326.","DOI":"10.1016\/B978-0-443-06839-3.00029-1"},{"key":"10.1016\/j.otc.2010.10.003_bib65","first-page":"172","article-title":"Antibiotic therapy of bacterial endocarditis. VII. Vancomycin for acute micrococcal endocarditis","volume":"33","author":"Geraci","year":"1958","journal-title":"Proc Staff Meet Mayo Clin"},{"issue":"2","key":"10.1016\/j.otc.2010.10.003_bib66","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1128\/AAC.01088-08","article-title":"Vancomycin ototoxicity: a re-evaluation in an era of increasing doses","volume":"53","author":"Forouzesh","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.otc.2010.10.003_bib67","doi-asserted-by":"crossref","unstructured":"Murray BE, Nannini EC. Glycopeptides (vancomycin and teicoplanin), streptogramins (quinipristin-dalfopristin), and lipopeptides (daptomycin). In: Mandell GL, Douglas RG, Bennett JE. Principles and practice of infectious diseases. 7th edition. Philadelphia (PA): Churchill, Livingstone Elsevier; 2010. p. 449\u201367.","DOI":"10.1016\/B978-0-443-06839-3.00031-X"},{"key":"10.1016\/j.otc.2010.10.003_bib68","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2165\/00003088-198611040-00001","article-title":"Clinical pharmacokinetics of vancomycin","volume":"11","author":"Matzke","year":"1986","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.otc.2010.10.003_bib69","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1093\/infdis\/168.3.773","article-title":"Prospective evaluation of red man syndrome in patients receiving vancomycin","volume":"168","author":"O\u2019Sullivan","year":"1993","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.otc.2010.10.003_bib70","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1001\/archinte.1989.00390080053013","article-title":"Mild nephrotoxicity associated with vancomycin use","volume":"149","author":"Downs","year":"1989","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.otc.2010.10.003_bib71","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/jac\/25.4.679","article-title":"Nephrotoxicity of vancomycin, alone or with an aminoglycoside","volume":"25","author":"Rybak","year":"1990","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.otc.2010.10.003_bib72","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1056\/NEJMoa065066","article-title":"Vancomycin-induced immune thrombocytopenia","volume":"356","author":"Von Drygalski","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.otc.2010.10.003_bib73","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1128\/AAC.23.1.138","article-title":"Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981","volume":"23","author":"Farber","year":"1983","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.otc.2010.10.003_bib74","first-page":"454","article-title":"Pharmacodynamics of daptomycin and vancomycin on Enterococcus faecalis and Staphylococcus aureus demonstrated by studies of initial killing and postantibiotic effect and influence of Ca2+ and albumin on these drugs","volume":"45","author":"Hanberger","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.otc.2010.10.003_bib75","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1128\/AAC.45.2.454-459.2001","volume":"45","author":"Akins","year":"2001","journal-title":"Antimicrobial Agents Chemother"},{"key":"10.1016\/j.otc.2010.10.003_bib76","doi-asserted-by":"crossref","first-page":"697","DOI":"10.5694\/j.1326-5377.1993.tb121918.x","article-title":"The efficacy of oral cotrimoxazole in the treatment of otitis externa in general practice","volume":"158","author":"Yelland","year":"1993","journal-title":"Med J Aust"},{"key":"10.1016\/j.otc.2010.10.003_bib77","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/00006454-200103000-00009","article-title":"Bacteriologic and clinical efficacy of trimethoprim-sulfamethoxazole for treatment of acute otitis media","volume":"20","author":"Leiberman","year":"2001","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.otc.2010.10.003_bib78","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1001\/archotol.1993.01880130105015","article-title":"Longterm sulfamethoxazole-trimethoprim in Wegener\u2019s granulomatosis","volume":"119","author":"McRae","year":"1993","journal-title":"Arch Otolaryngol"},{"key":"10.1016\/j.otc.2010.10.003_bib79","doi-asserted-by":"crossref","unstructured":"Rex JH, Stevens DA. Systemic antifungal agents. In: Mandell GL, Bennett JE, Douglas RG. Principles and practice of infectious diseases. 7th edition. Philadelphia (PA): Churchill, Livingstone Elsevier; 2010. p. 549\u201363.","DOI":"10.1016\/B978-0-443-06839-3.00040-0"},{"issue":"1","key":"10.1016\/j.otc.2010.10.003_bib80","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jaci.2004.09.037","article-title":"Treatment of chronic rhinosinusitis with intranasal amphotericin B: a randomized, placebo-controlled, double-blind pilot trial","volume":"115","author":"Ponikau","year":"2005","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.otc.2010.10.003_bib81","article-title":"Antiviral therapy for Ramsay Hunt syndrome (herpes zoster oticus with facial palsy) in adults","volume":"4","author":"Uscategui","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.otc.2010.10.003_bib82","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.otohns.2007.09.018","article-title":"Risk factors for surgical site infections in head and neck cancer surgery","volume":"138","author":"Lofti","year":"2008","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.otc.2010.10.003_bib83","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1177\/000348948909800501","article-title":"Microbiology of wound infection after head and neck cancer surgery","volume":"98","author":"Brook","year":"1989","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.otc.2010.10.003_bib84","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.idc.2007.03.007","article-title":"Cervicofacial actinomycosis and mandibular osteomyelitis","volume":"21","author":"Sharkawy","year":"2007","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.otc.2010.10.003_bib85","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0891-5520(05)70111-2","article-title":"Oral microflora as a cause of endocarditis and other distant site infections","volume":"13","author":"Lockhart","year":"1999","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.otc.2010.10.003_bib86","first-page":"324","article-title":"A\u00a0rare complication of tooth abscess-Ludwig\u2019s angina and mediastinitis","volume":"67","author":"Furst","year":"2001","journal-title":"J\u00a0Can Dent Assoc"},{"key":"10.1016\/j.otc.2010.10.003_bib87","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0901-5027(05)80707-6","article-title":"Mediastinitis from odontogenic infection. Report of three cases and review of the literature","volume":"20","author":"Garatea-Crelgo","year":"1991","journal-title":"Int J Oral Maxillofac Surg"}],"container-title":["Otolaryngologic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003066651000215X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003066651000215X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,13]],"date-time":"2021-11-13T21:28:53Z","timestamp":1636838933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003066651000215X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":86,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S003066651000215X"],"URL":"https:\/\/doi.org\/10.1016\/j.otc.2010.10.003","relation":{},"ISSN":["0030-6665"],"issn-type":[{"value":"0030-6665","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}